BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Said I, Ahad H, Said A. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World J Gastrointest Oncol 2022; 14(5): 947-958 [PMID: 35646285 DOI: 10.4251/wjgo.v14.i5.947]
URL: https://www.wjgnet.com/2218-4333/full/v14/i5/947.htm
Number Citing Articles
1
Maryam K. Ibrahim, Tracey G. Simon, Mary E. Rinella. Extrahepatic Outcomes of Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2023; 27(2): 251 doi: 10.1016/j.cld.2023.01.004
2
Mohamed Salaheldin, Heba Aly, Louis Lau, Shimaa Afify, Mohamed El-Kassas. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral HepatitisDiagnostics 2023; 13(16): 2631 doi: 10.3390/diagnostics13162631
3
Connor Campbell, Mrunmayee R. Kandalgaonkar, Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar, Piu Saha. Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and ImmunotherapyBiomedicines 2023; 11(2): 294 doi: 10.3390/biomedicines11020294
4
Jie-ping Wang, Meng-yu Zhang, Ming Luo, Shu Qin, Xian-ming Xia. Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in ratsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23539-5
5
Rui Xiao, Yang Cao, Linlin Wang, Peijun Tian, Qixiao Zhai, Jianxin Zhao, Gang Wang, Yu Zhu. The role of probiotics in the treatment of non-alcoholic fatty liver disease (NAFLD): New insights based on meta-analysis and subgroup analysisFood Bioscience 2024; 62: 105454 doi: 10.1016/j.fbio.2024.105454
6
Stergios A. Polyzos, Lampros Chrysavgis, Ilias D. Vachliotis, Evangelos Chartampilas, Evangelos Cholongitas. Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapySeminars in Cancer Biology 2023; 93: 20 doi: 10.1016/j.semcancer.2023.04.010
7
阳阳 张. Discussion on the Influence of Intestinal Flora Disturbance on Diabetic Nephropathy and the Treatment of Traditional Chinese Medicine Based on the Theory of “Entero-Renal Axis”Traditional Chinese Medicine 2024; 13(09): 2435 doi: 10.12677/tcm.2024.139361
8
Ming Ren Toh, Evelyn Yi Ting Wong, Sunny Hei Wong, Alvin Wei Tian Ng, Lit-Hsin Loo, Pierce Kah-Hoe Chow, Joanne Ngeow. Global Epidemiology and Genetics of Hepatocellular CarcinomaGastroenterology 2023; 164(5): 766 doi: 10.1053/j.gastro.2023.01.033
9
Tamiris Ingrid Petito‐da‐Silva, Felipe Missiba Villardi, Aline Penna‐de‐Carvalho, Carlos Alberto Mandarim‐de‐Lacerda, Vanessa Souza‐Mello, Sandra Barbosa‐da‐Silva. An Intestinal FXR Agonist Mitigates Dysbiosis, Intestinal Tight Junctions, and Inflammation in High‐Fat Diet‐Fed MiceMolecular Nutrition & Food Research 2024; 68(4) doi: 10.1002/mnfr.202300148
10
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, Lucia Cerrito, Francesco Santopaolo, Leonardo Stella, Antonio Gasbarrini, Francesca Romana Ponziani. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver CancersNutrients 2024; 16(14): 2372 doi: 10.3390/nu16142372
11
Ernesto Saenz, Nathally Espinosa Montagut, Baohong Wang, Christoph Stein-Thöringer, Kaicen Wang, Honglei Weng, Matthias Ebert, Kai Markus Schneider, Lanjuan Li, Andreas Teufel. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesEngineering 2024; 40: 51 doi: 10.1016/j.eng.2024.03.019
12
Rong Feng, Liang Chen, Ming Yang. Aluminum-induced oxidative stress promotes changes in the structure of the gut microbiota and liver deficiencyHeliyon 2024; 10(16): e36165 doi: 10.1016/j.heliyon.2024.e36165
13
Sara Tharwat Abdullah, Snur Rasool Abdullah, Bashdar Mahmud Hussen, Yousif Mohammed Younis, Mohammed Fatih Rasul, Mohammad Taheri. Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targetsNon-coding RNA Research 2024; 9(1): 236 doi: 10.1016/j.ncrna.2023.12.002